Related Experiment Video
Updated: Apr 22, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Using multivariable Mendelian randomization to disentangle the causal effects of lipid fractions
Stephen Burgess1, Daniel F Freitag1, Hassan Khan1
1Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, Cambridgeshire, United Kingdom.
Insights
High-density lipoprotein cholesterol (HDL-c) may be causally protective against coronary artery disease (CAD), independent of low-density lipoprotein cholesterol (LDL-c) and triglycerides. This finding suggests potential therapeutic benefits of targeting HDL-c for CAD risk reduction.
Area of Science:
- Genetics
- Cardiovascular Disease Epidemiology
- Biochemistry
Background:
- Previous studies suggested a causal role for LDL-c and triglycerides in CAD risk.
- However, the causal link between HDL-c and CAD risk remained uncertain, with some evidence suggesting no significant association.
Purpose of the Study:
- To investigate the independent causal effects of HDL-c, LDL-c, and triglycerides on coronary artery disease (CAD) risk.
- To clarify the role of HDL-c in CAD etiology using advanced Mendelian randomization methods.
Main Methods:
- Employed multivariable Mendelian randomization using published data.
- Analyzed associations between 185 lipid-related genetic variants, lipid fractions (in 188,578 participants), and CAD risk (in 22,233 cases and 64,762 controls).
- Focused on genetic variants without pleiotropic associations with blood pressure or BMI.
Main Results:
- Multivariable Mendelian randomization indicated that HDL-c may be causally protective against CAD, independent of LDL-c and triglycerides.
- Estimated odds ratios per standard deviation increase: LDL-c (1.57), HDL-c (0.91, p=0.028), triglycerides (1.29).
- Results suggest HDL-c has an independent protective association with CAD risk.
Conclusions:
- Interventions targeting HDL-c concentrations may influence CAD risk, though potentially to a lesser extent than LDL-c interventions.
- The causal interpretation assumes no pleiotropic associations of genetic variants with other CAD risk factors.
- Genetic predictors of LDL-c, HDL-c, and triglycerides demonstrate independent associations with CAD risk.
Background:
Previous Mendelian randomization studies have suggested that, while low-density lipoprotein cholesterol (LDL-c) and triglycerides are causally implicated in coronary artery disease (CAD) risk, high-density lipoprotein cholesterol (HDL-c) may not be, with causal effect estimates compatible with the null.
Principal Findings:
The causal effects of these three lipid fractions can be better identified using the extended methods of 'multivariable Mendelian randomization'. We employ this approach using published data on 185 lipid-related genetic variants and their associations with lipid fractions in 188,578 participants, and with CAD risk in 22,233 cases and 64,762 controls. Our results suggest that HDL-c may be causally protective of CAD risk, independently of the effects of LDL-c and triglycerides. Estimated causal odds ratios per standard deviation increase, based on 162 variants not having pleiotropic associations with either blood pressure or body mass index, are 1.57 (95% credible interval 1.45 to 1.70) for LDL-c, 0.91 (0.83 to 0.99, p-value = 0.028) for HDL-c, and 1.29 (1.16 to 1.43) for triglycerides.
Significance:
Some interventions on HDL-c concentrations may influence risk of CAD, but to a lesser extent than interventions on LDL-c. A causal interpretation of these estimates relies on the assumption that the genetic variants do not have pleiotropic associations with risk factors on other pathways to CAD. If they do, a weaker conclusion is that genetic predictors of LDL-c, HDL-c and triglycerides each have independent associations with CAD risk.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Randomized Experiments
Simple randomization
Simple...
Pharmacogenomics: Identification of New Drug Targets
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...